Naproxcinod Completed Phase 3 Trials for Osteoarthritis (OA) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00542555Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee